Seeking Alpha

Pfizer (PFE) announces a deal worth up to $725M to develop and commercialize Medivation's (MDVN)...

Pfizer (PFE) announces a deal worth up to $725M to develop and commercialize Medivation's (MDVN) Alzheimer's drug. Pfizer is trying to expand its product pipeline before blockbuster Lipitor loses its patent protection. Pre-market: MDVN +28%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|